The Childhood Cancer Blog
The Childhood Cancer Blog
Josie was 5 months old when she was diagnosed with juvenile myelomonocytic leukemia (JMML), a rare pediatric leukemia without many effective treatment options. Thanks to an ALSF Center of Excellence Grant, Josie could access a brand-new clinical trial offering upfront treatment: a potential cure without long-term side effects.
As the year ends, many of us are searching for meaningful ways to give back and make an impact. In a year marked by uncertainty, shifting Federal research priorities, and changes in science funding, one thing remains clear: children with cancer cannot wait. Your support is more important than ever.
This year, you can join the movement to fund critical research, support families, and help find safer treatments and cures for childhood cancer through Alex’s Lemonade Stand Foundation (ALSF). Since 2000, ALSF has funded more than 1,500 research grants, fueling breakthroughs and... Read More
The ALSF Centers of Excellence grant program has increased the number of clinical trials and helped real kids get their cures, like little Josie (above), who thanks to COE funding, was able to access a life-saving trial close to home.
Every breakthrough in childhood cancer starts the same way: with someone choosing to act — whether it's a researcher with a bold idea or a donor committed to giving kids a chance at a cure.
Alex’s Lemonade Stand Foundation (ALSF) founder Alex Scott believed if we all worked together, we could make a difference for kids with cancer, and when it comes to childhood cancer research, nothing could be truer. Childhood cancer research needs the brightest minds, the most curious investigators, and the most generous supporters to power it forward toward cures.
“This research is... Read More
ALSF Founder Alex Scott was diagnosed with neuroblastoma in 1997.
Cole beat neuroblastoma; but did not know until 15 years and another cancer later that he had Li Fraumeni, a cancer predisposition syndrome. Cole passed away at age 19.
Arden, diagnosed over a decade after Alex, had newer, less toxic and more effective treatment options, thanks to research.
Tony beat neuroblastoma as a young child but was left with long term side effects.
When Alex’s Lemonade Stand Foundation (ALSF) Founder Alex Scott was diagnosed with neuroblastoma in 1997, doctors didn’t know her cancer was driven by ALK – a mutation that fuels the development of neuroblastoma cells. And even if they did, there wasn’t a treatment in 1997 for ALK-driven neuroblastoma.
But today, there are effective treatment options for that type of neuroblastoma, thanks to research.
Over the past two decades, incredible progress has been made in the treatment of neuroblastoma. From identifying targets and developing drugs to leveraging genetic testing... Read More
Pages
